India to outrun China in 15 years : Deutsche Bank study

Clinical Trials : 20 per cent of all clinical trials conducted globally will be from India It is estimated that about 20 per cent of all clinical trials conducted globally will be from India by 2010. Over two millions people will be participating in clinical studies in India by that time. Last year, over nine million patients participated in clinical trials globally, Dr Vijai Kumar, president and CEO, Neeman Medical International, said. India has advantage in contract research due to the availability of manpower, large patient base, good infrastructure, stable legal system, good regulatory practices, adherence to ethical guidelines for human and biomedical research and large number of English speaking professionals, he added. Indian CROs have a good future as indigenous companies need support from them, besides global companies. The CROs can enter into alliances with their counterparts in other countries and enable Indian pharmaceutical companies to conduct studies in those countries, Dr Kumar said. (Ref : "Chronicle Pharmabiz" April 14, 2005)